Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Florida: The Complete Guide for Women, Families, and Survivors
For women in Florida who have undergone breast reconstruction after a cancer diagnosis, a prophylactic mastectomy, or an aesthetic enhancement, the expectation is always one of healing and restoration. Whether you were treated at a world-renowned institution like the Moffitt Cancer Center in Tampa, the University of Miami’s Sylvester Comprehensive Cancer Center, or a specialized surgical center in Boca Raton or Jacksonville, you placed your trust in the medical devices implanted in your body. When surgical mesh, acellular dermal matrix (ADM), or bioabsorbable scaffolds like GalaFLEX fail, that trust is shattered by pain, infection, and the devastating loss of reconstruction.
At Attorney911 (The Manginello Law Firm, PLLC), we recognize that you are navigating one of the most challenging chapters of your life. We represent women across Florida—from the high-volume medical hubs of Miami-Dade and Broward Counties to the growing surgical centers in Orlando and the Panhandle—who are suffering because of manufacturers who prioritized market speed over patient safety. Our managing partner, Ralph Manginello, has spent twenty-seven years fighting for the catastrophically injured, bringing a technical and doctrinal rigor to product liability that generalist firms often lack. Together with associate attorney Lupe Peña, who brings a distinct advantage from his background in insurance defense and provides full consultations in fluent Spanish, we investigate the regulatory failures that allowed these devices into Florida operating rooms.
If you are experiencing hardness, redness, chronic pain, or have been diagnosed with a rare cancer like BIA-ALCL, you deserve answers rooted in the law and the science. You can reach us at 1-888-ATTY-911 (1-888-288-9911) for a confidential, no-obligation conversation about what happened to your body and what the law in Florida allows you to do next.
Understanding the Devices: Surgical Mesh, ADM, and Scaffolds in Florida Breast Surgery
To understand your legal options, we must first look at the technology used in your procedure. In Florida, surgeons often use three categories of products to support a breast implant or tissue expander—a technique frequently marketed as the “internal bra.”
Acellular Dermal Matrix (ADM)
Acellular dermal matrix is a biological graft typically derived from human cadaver skin or animal tissue (porcine or bovine). These grafts are processed to remove cells while leaving the structural collagen matrix intact, allowing your own tissue to grow into the scaffold. Brands common in Florida hospitals include AlloDerm (Allergan/AbbVie), Strattice, and FlexHD. While marketed as a natural solution for lower-pole support, large-scale studies have shown that certain ADMs significantly increase the risk of infection and reoperation.
Bioabsorbable and Bioresorbable Scaffolds
Unlike permanent mesh, these synthetic scaffolds are designed to provide temporary support and then dissolve—or “resorb”—as your body builds new tissue. The most prominent example in Florida litigation is GalaFLEX, made of poly-4-hydroxybutyrate (P4HB). Other brands include Phasix and DuraSorb. The primary controversy involves the failure of these materials to absorb on the manufacturer’s promised 12-to-24-month timeline, leading to palpable mesh edges, chronic inflammation, and “bottoming out” once the scaffold finally disappears.
Synthetic Surgical Mesh
Occasionally, permanent synthetic meshes made of polypropylene (similar to hernia mesh) are used off-label in breast surgery. These materials were never designed for the delicate environment of breast tissue and can cause severe erosion and chronic neuropathic pain.
If you underwent surgery in Florida and suspect one of these materials was used, we can help you secure your operative reports to identify the exact brand and lot number. Knowing whether you have a GalaFLEX scaffold or a FlexHD matrix is the first step toward building a case. Contact Ralph Manginello and the team at 1-888-ATTY-911 for help navigating this investigative process.
The FDA Regulatory Timeline: A History of Missed Warnings
A central pillar of our litigation strategy at Attorney911 involves the FDA’s own admissions regarding these devices. Many Florida patients are surprised to learn that the mesh and ADM used in their breasts were never actually “approved” for that use. Instead, they reached the market through the 510(k) clearance pathway—a regulatory shortcut that only requires a manufacturer to show their device is “substantially equivalent” to an older product.
Verbatim FDA Admissions
The FDA’s stance on these products has shifted dramatically in recent years. In a critical letter to health care providers dated November 9, 2023, the FDA stated:
“The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”
This was not a new concern. In March 2021, the FDA issued a safety communication naming FlexHD and AlloMax as products with significantly higher rates of explantation, reoperation, and infection. Despite these warnings, manufacturers continued to market these devices to Florida surgeons for off-label use.
The Recall of Allergan BIOCELL
Florida’s aesthetic and reconstructive markets were heavily impacted by the July 24, 2019, recall of Allergan BIOCELL textured implants. The FDA requested this recall after data showed that patients with these textured surfaces were approximately six times more likely to develop BIA-ALCL, a rare T-cell lymphoma. If your reconstruction involved a combination of BIOCELL implants and ADM, your risk profile is uniquely complex, and you should reach out to us at 1-888-ATTY-911 to discuss the Allergan BIOCELL MDL 2921 currently pending in federal court.
The Science of Failure: Why These Devices Cause Injury
At our firm, we look beyond the surface level of “complications” to the hyper-scientific mechanisms of how these materials interact with human tissue. Ralph Manginello and Lupe Peña focus on the following documented failure modes that affect Florida patients:
Biofilm and Chronic Inflammation
Textured surfaces on implants and the macroporous structure of scaffolds like GalaFLEX are breeding grounds for bacterial biofilm. This biofilm can trigger a chronic immune response that leads to capsular contracture (the painful hardening of the breast) or, in severe cases, the development of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Red Breast Syndrome (RBS)
This is an ADM-specific sterile inflammation often mistaken for a standard infection. Research, including a notable study by Nguyen et al. (2019), suggests RBS is caused by bacterial endotoxins left on the matrix during the manufacturing process. For a woman in Florida dealing with persistent redness that doesn’t respond to antibiotics, RBS is a likely culprit. We use this science to argue that the manufacturer’s terminal sterilization was inadequate, constituting a manufacturing defect.
P4HB Hydrolysis Kinetics
In scaffolds like GalaFLEX, the P4HB material must degrade at a rate that matches tissue maturation. If it degrades too fast, the reconstruction sags (“bottoming out”). If it fails to resorb, it remains as a late-stage foreign body. This mismatch in resorption kinetics is a primary allegation in the emerging GalaFLEX litigation in which we are currently active.
Florida Legal Context: Navigating Statutes and Venues
If you were injured in Florida, the legal framework is distinct and requires an attorney who understands the 2023 legislative changes to Florida law.
The Two-Year Statute of Limitations
Under Florida Statutes § 95.11(3)(a), as amended in 2023, the statute of limitations for negligence is now two years. This is an aggressive deadline. If you discovered your injury was linked to a defective mesh or ADM more than two years ago, you may be barred from filing unless the discovery rule applies. The discovery rule in Florida can extend this period to the date you reasonably should have connected the injury to the device—often prompted by the FDA’s 2023 warning letter.
The Twelve-Year Statute of Repose
Florida Statutes § 95.031 imposes a 12-year statute of repose on most product liability actions. However, there is a critical exception: if the manufacturer was aware of the defect and deliberately concealed it, the repose period may not apply. This is where the whistleblower record of Dr. Hooman Noorchashm becomes vital.
Federal Court Venues in Florida
Depending on where your surgery occurred, your case would likely be heard in one of three federal districts:
- Southern District of Florida (Miami/Ft. Lauderdale): A high-volume venue for device litigation given the density of cosmetic and reconstructive surgery in South Florida.
- Middle District of Florida (Tampa/Orlando/Jacksonville): Home to institutions like Moffitt Cancer Center.
- Northern District of Florida (Tallahassee/Pensacola).
Ralph Manginello is admitted to the United States District Court for the Southern District of Texas and coordinates with local counsel across Florida federal districts to ensure our clients’ cases are positioned correctly within the multidistrict litigation (MDL) framework.
The Whistleblower: Dr. Hooman Noorchashm’s Allegations
One of the most powerful tools in our arsenal is the public record of Dr. Hooman Noorchashm. A cardiothoracic surgeon and former Medical Director at Becton Dickinson (BD), Dr. Noorchashm was terminated in 2022 after raising alarms about GalaFLEX and Phasix.
Specifically, Dr. Noorchashm has alleged that BD withheld data regarding breast cancer recurrences in GalaFLEX clinical trials and failed to properly report adverse events to the FDA’s MAUDE database. He has publicly warned Florida surgeons that the malpractice liability for using these non-standard devices rests on their shoulders, while the manufacturer continues to profit from off-label promotion. At Attorney911, we integrate these whistleblower facts to pierce the “learned intermediary” defense and show that manufacturers actively misled the Florida medical community.
Who Is At Risk? The Patient Profiles We Represent
At Attorney911, we speak directly to several distinct groups of women in Florida:
- The Breast Cancer Survivor: You underwent a mastectomy at a Florida cancer center and received an ADM-assisted reconstruction. You are now facing “skin-flap necrosis” or a deep surgical site infection that has forced the removal of your implants.
- The Cosmetic Augmentation Patient: You sought a breast lift (“mastopexy”) or augmentation in Miami or Tampa, and your surgeon used a GalaFLEX scaffold for reinforcement. You now feel the hard, sharp edges of the mesh under your skin, or your breasts have lost their shape prematurely.
- The BIA-ALCL or BIA-SCC Patient: You have been diagnosed with a rare cancer linked to your textured implants. You need a law firm that understands CD30+ ALK- pathology and the bellwether trial deadlines in MDL 2921.
- The Spanish-Speaking Community: Many Florida patients find that informed consent materials were never provided in their native language. At Attorney911, associate attorney Lupe Peña conducts full consultations in fluent Spanish, ensuring our clients fully understand their rights without the barrier of a translator. Hablamos español y estamos listos para ayudarle.
Regardless of which group you fall into, the path forward starts with a single call to 1-888-ATTY-911.
Why Choose Attorney911 for Your Florida Device Claim?
Choosing a law firm for a defective medical device case is different from choosing a lawyer for a fender bender. You need a firm with institutional-litigation experience.
The Bermudez v. Pi Kappa Phi Authority Signal
Our firm is currently lead counsel in Bermudez v. Pi Kappa Phi, filed in November 2025, seeking $10,000,000 in damages. This high-profile case involves 13 defendants, including a major university system. It is a testament to our ability to handle complex, multi-party litigation against powerful institutions—exactly the type of structural battle required to win against billion-dollar device manufacturers like Becton Dickinson (BD), Allergan, and Johnson & Johnson.
Verifiable Credentials
Ralph Manginello’s practice is backed by twenty-seven years of continuous licensure (Texas Bar #24007597) and admitting to the Southern District of Texas. His independent ratings include a Martindale-Hubbell Preeminent 5.0 of 5.0 and an Avvo “Excellent” rating. We don’t just claim capability; we point to the hundreds of reviews and peer endorsements that confirm it.
Insider Knowledge
Lupe Peña’s background in insurance defense provides us with an “insider” view of how carriers value claims. We know the low-ball tactics the device manufacturers’ insurers use in Florida, and we know how to counter them before they can derail your recovery.
Frequently Asked Questions for Florida Residents
Is surgical mesh FDA-approved for breast surgery?
No. As the FDA stated in its 2023 letter to health care providers, no surgical mesh (including ADM or bioabsorbable scaffolds) has been cleared or approved specifically for breast reconstruction or augmentation. They are used “off-label” in Florida based on 510(k) clearances for general soft-tissue reinforcement.
How do I find out which brand of mesh was used in my surgery?
You have a legal right to your medical records. You must request the “Operative Report” and the “Implant Log” from the Florida hospital or surgical center where your procedure was performed. These documents contain the Unique Device Identifier (UDI) stickers with the brand, model, and lot number of everything implanted in your body.
What is the discovery rule in Florida?
The discovery rule allows the two-year statute of limitations to start when you discovered (or should have discovered) that your injury was caused by the defective product, rather than the date of the surgery itself. In your case, this might be when you received a BIA-ALCL diagnosis or when you read the FDA’s warning about GalaFLEX complications.
What if my surgery was at a prominent Florida cancer center? Does that mean I can’t sue?
Even at the most respected hospitals, surgeons were often misled by manufacturer marketing. Our lawsuits are typically filed against the device manufacturers for failure to warn and design defects. While we investigate if there was hospital or surgeon negligence, the focus remains on the companies that put a dangerous product on the market.
What does it cost to hire an attorney at Attorney911?
We operate on a contingency fee basis. This means we advance all the costs of litigation—which can be substantial in medical device cases involving expert pathology and regulatory witnesses—and you pay nothing unless we recover compensation for you.
Competing Against the “Learned Intermediary” Defense
When we file a lawsuit in Florida, the manufacturer’s first move is almost always the “learned intermediary” defense. They will argue that they warned your Florida surgeon of the risks, and therefore, any failure to inform you is the surgeon’s fault.
We defeat this by showing that the manufacturers’ off-label promotion was so aggressive that it “poisoned the well.” When a GalaFLEX or AlloDerm sales rep is in the Florida operating room providing guidance, or when they sponsor continuing medical education (CME) in South Florida that only highlights the benefits without mentioning the infection rates, they have effectively bypassed the surgeon’s independent judgment. We hold them accountable for the misinformation campaign that reached your bedside.
Evidence Preservation: Steps for Florida Patients
If you are scheduled for a revision or permanent removal surgery in Florida, you must act before you go into the operating theater.
- Request Device Preservation: Ask your surgeon and the hospital pathology department to preserve any explanted mesh, ADM, or scaffold. Manufacturers often try to have these “returned” to them for analysis, where they can be lost. Our team at 1-888-ATTY-911 can issue a formal preservation letter to ensure the device is kept as evidence.
- Secure Pathology Slides: If you have been diagnosed with BIA-ALCL or BIA-SCC, the physical pathology slides from your Florida hospital are the most important evidence in your case. We can help you secure these for independent review by board-certified oncological pathologists.
- Document Symptoms: Use your phone to photograph any visible skin redness, “red breast syndrome,” or mesh extrusion. Keep a journal of your pain levels and any systemic symptoms (fatigue, joint pain) which may indicate Breast Implant Illness (BII).
Florida Resources for Recovery
While we handle the legal battle, Florida survivors have access to world-class support networks. We recommend the following independent resources:
- The Moffitt Cancer Center’s Breast Cancer Program (Tampa) for oncological second opinions.
- Susan G. Komen Florida (serving South Florida and the Gulf Coast) for patient navigation.
- SHARE Cancer Support’s LatinaSHARE for Spanish-language peer support in Florida.
If you need help finding a specialist in Florida for an independent evaluation of your mesh complications, our team can provide guidance on finding providers who are not affiliated with the manufacturer’s study groups.
Take the Next Step Toward Justice in Florida
The physical and emotional toll of a failed breast reconstruction is something no woman should have to bear alone. Whether you are in Miami, Jacksonville, Orlando, or Tampa, the team at Attorney911 is ready to stand with you. Ralph Manginello’s twenty-seven years of experience and Lupe Peña’s bilingual advocacy provide the powerful, compassionate representation you need to take on the manufacturers.
Do not allow a statute of limitations to expire while you wait for answers. The FDA has already sounded the alarm; the whistleblowers have already spoken. It is time for you to have your voice heard.
Contact us today at 1-888-ATTY-911 (1-888-288-9911) for a free, confidential consultation. If you prefer to speak in Spanish, ask for Lupe Peña. We work on a contingency fee basis—no recovery, no fee. We are your advocates for justice in Florida.
Attorney Advertising Disclaimer: This content is for educational purposes only and does not constitute legal advice. No attorney-client relationship is formed until a written representation agreement is signed. Past results, including the Bermudez v. Pi Kappa Phi litigation, do not guarantee future outcomes. The Manginello Law Firm, PLLC (Attorney911) maintains its principal office in Houston, Texas, and represents clients in Florida through federal court admission and coordination with local counsel as required. Free consultations provided daily. Call 1-888-ATTY-911.
